为所有孕妇开展基因组测序:通过患者反思探索产前诊断的新前沿
本研究通过半结构化访谈探讨孕妇在无胎儿异常情况下获得产前基因组测序结果后的反思。共访谈21名参与者(代表15次妊娠),采用建构主义扎根理论分析。参与者动机各异但均希望获得最大信息量,阳性结果几乎均带来下游影响,阴性结果提供 reassurance,多数人未来妊娠愿意再次检测但对费用和可及性有顾虑。
要点
- 参与者追求基因组测序的动机多样,但均希望获得最大信息量。
- 阳性结果几乎均带来下游影响,包括终止妊娠、级联检测、转诊专科及妊娠管理和新生儿护理改变。
- 阴性结果为妊娠和儿童早期发育提供 reassurance,多数参与者未来妊娠愿意再次检测。
核心结论
- 理解孕妇及其伴侣的观点和需求有助于为将基因组测序作为一线产前诊断检测的实施提供信息。
研究设计与样本
- 邀请同意未来研究的参与者进行半结构化访谈,参与者为英语使用者,距测序妊娠结束30天至1年。
- 共对21名参与者(3对夫妇同时访谈)进行了18次访谈,代表15次独特妊娠(81%足月分娩,14%终止妊娠,5%早产)。
- 访谈转录、编码并采用建构主义扎根理论方法分析。
主要发现
- 参与者追求基因组测序的动机多样,但均希望获得最大信息量。
- 几乎所有阳性结果参与者均有下游影响,包括终止妊娠、级联检测、转诊专科以及妊娠管理和新生儿护理改变。
- 阴性结果为妊娠和儿童早期发育提供 reassurance。
- 若可用,大多数参与者愿意在未来妊娠中追求基因组测序;少数人对费用和可及性提出顾虑。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to explore participant reflections after receipt of prenatal genome sequencing (GS) results in the absence of fetal anomalies. METHODS: Participants invited to complete a semi-structured interview consented to future research, were English speaking, and were between 30 days and 1 year since the conclusion of their sequenced pregnancy. A total of 18 interviews were conducted with 21 participants (3 couples interviewed concurrently) representing 15 unique pregnancies (81% term deliveries, 14% terminated pregnancies, and 5% preterm delivery). Interviews were transcribed, coded, and analyzed using a constructivist grounded theory approach. RESULTS: Participants had various motivations for pursuing GS, yet all wanted maximal information. Almost all participants with positive results had downstream implications, including termination, cascade testing, referral to specialists, and changes in pregnancy management and neonatal care. Negative results provided reassurance for the pregnancy and child's early development. If available, most participants would pursue GS in a future pregnancy; however, a few raised concerns about cost and accessibility. CONCLUSION: Understanding the perspectives and needs of pregnant patients and their partners will help inform the implementation of GS as a first-tier prenatal diagnostic test.
引用
- Kelly KE, Galloway S, Demers A, et al. Genome Sequencing for All Pregnant Persons: Navigating the Next Frontier in Prenatal Diagnosis Through Patient Reflections. Prenat Diagn. 2025. PMID: 40913754. doi:10.1002/pd.6884
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。